Premium
Omni Bridgeway Ltd (PK) (IMMFF)
USOTC
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
VANCOUVER, British Columbia, Aug. 10, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF), reports that its business partner Immunitor company has launched a Phase 2 clinical trial...
VANCOUVER, British Columbia, July 9, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Immunitor's investigators presented final results from its imm01 clinical trial...
VANCOUVER, British Columbia, July 7, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that clinical results from its new tableted form of Immunoxel (Dzherelo) product...
Agreement to fast-track introduction of new Immunoxel/Dzherelo tablet as adjunct immunotherapy, especially for MDR-TB VANCOUVER, British Columbia, May 30, 2011 (GLOBE NEWSWIRE) -- Immune...
VANCOUVER, British Columbia, March 3, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Ukrainian company Ekomed LLC has agreed to collaborate with Immune Network and...
VANCOUVER, B.C., Feb. 28, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis...
VANCOUVER, British Columbia, Feb. 14, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) is pleased to announce that a co-founder of Immunitor, Dr. Aldar Bourinbaiar, has joined...
VANCOUVER, British Columbia, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF) a company in the business of development and commercialization of immune therapies...
VANCOUVER, British Columbia, Jan. 17, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises progress is being made toward the acquisition of Immunitor Inc., a Canadian...
VANCOUVER, British Columbia, Dec. 30, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that Immunitor has published data from the first half of the 120-patient imm01...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.5 | 0.5 | 0.5 | 0 | 0 | CS |
| 26 | -0.11 | -18.0327868852 | 0.61 | 0.61 | 0.5 | 20 | 0.5 | CS |
| 52 | -0.3993 | -44.4012009341 | 0.8993 | 0.9897 | 0.5 | 2434 | 0.67291888 | CS |
| 156 | -1.7 | -77.2727272727 | 2.2 | 3.22925 | 0.5 | 3283 | 1.75673574 | CS |
| 260 | -1.35 | -72.972972973 | 1.85 | 6.9 | 0.5 | 6837 | 2.63356546 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| CBDLCBD Life Sciences Inc (PK) | US$ 0,0004 (33,33%) | 237,45M |
| RDARRaadr Inc (PK) | US$ 0,0006 (-14,29%) | 212,99M |
| CGACCode Green Apparel Corp (PK) | US$ 0,00045 (-35,71%) | 196,42M |
| AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,0034 (29,52%) | 174,82M |
| NSAVNet Savings Link Inc (PK) | US$ 0,0008 (-55,56%) | 170,05M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
